Malin Corporation | MLC - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
ALKERMES USD 285.82M 639K 2024-09
Avita Medical AUD 42.24M 1.25M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Eurofins Scientific SE EUR 3.7B 129.7M 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Lonza CHF 3.88B 323M 2025-12
Malin Corporation EUR 0 0 2024-12
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Ovoca Bio EUR 0 0 2021-06
Revvity USD 2.63B 543K 2025-12
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12